Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972
Year: 2003
Type: article
Study design: Clinical Trial
Source: Annals of Oncology
Institutions: Erasmus MC, Hôpital de la Timone, The Netherlands Cancer Institute, Instituto Português de Oncologia Francisco Gentil, University Medical Center Utrecht, Medisch Centrum Haaglanden, Stichting Haaglanden Medisch Centrum, European Organisation for Research and Treatment of Cancer, European Organisation for Research and Treatment of Cancer
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2123453386
